Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers study potential cancer suppression in cetaceans
Researchers sequenced and assembled the genome of a humpback whale.
Findings could help find new treatments for human cancers 

A study of potential cancer suppression in cetaceans could help researchers discover new targets for preventing cancer in humans.

The research, published in Molecular Biology and Evolution, pulled apart the genome of a humpback whale, along with nine other cetaceans, to reveal how their cancer defences are so effective.

Study leader Professor Marc Tollis from Northern Arizona University said the study found ‘nature has beaten cancer in countless ways across the tree of life’.

He added that scientists can use the information to help find new treatments for human cancers. For example, using the whale version of a protein that can prevent cell growth to develop drugs that shrink tumours in humans.

“Our goal is not only to get nature to inform us about better cancer therapies but to give the public a new perspective of cancer,” Tollis said. “The fact that whales and elephants evolved to beat cancer, and that dinosaurs suffered from it as well, suggests that cancer has been a selective pressure across many millions of years of evolution, and it has always been with us.

“Our hope is that this may change people’s relationship with the disease, which can be painful and personal. It also helps provide even better appreciation for biodiversity. In our current sixth mass extinction, we need all the reasons for conservation that we can get.”

In the study, researchers sequenced and assembled the genome of a humpback whale and compared it to other mammals. These included the blue whale, fin whale, bowhead whale and sperm whale.

They found that some parts of the whale genome contained genes that control the cell cycle, cell proliferation and DNA repair, which are essential for normal cell function. Many of these genes are mutated in human cancers. They also found that the whale genome also evolved many duplications in tumour suppressor genes.

Co-author Carlo Maley from Arizona State University said: “Nature is showing us that these changes to cancer genes are compatible with life. The next questions are, which of these changes is preventing cancer, and can we translate those discoveries into preventing cancer in humans?”

Tollis added: “This suggests that whales are unique among mammals in that in order to evolve their gigantic sizes, these important ‘housekeeping’ genes, that are evolutionarily conserved and normally prevent cancer, had to keep up in order to maintain the species’ fitness.

“We also found that despite these cancer-related parts of whale genomes evolving faster than other mammals, on average whales have accumulated far fewer DNA mutations in their genomes over time compared to other mammals, which suggests they have slower mutation rates.”

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.